S Pandolfi
Overview
Explore the profile of S Pandolfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tirelli U, Valdenassi L, Franzini M, Pandolfi S, Fisichella R, Chirumbolo S
Eur Rev Med Pharmacol Sci
. 2023 Dec;
27(23):11643-11652.
PMID: 38095411
Objective: In patients with breast cancer and positive hormone receptors, aromatase inhibitors are effective in reducing the risk of recurrences and are active in progressing the disease in this setting....
2.
Tirelli U, Franzini M, Valdenassi L, Pandolfi S, Taibi R, Chirumbolo S
Eur Rev Med Pharmacol Sci
. 2022 Nov;
26(21):7974-7979.
PMID: 36394747
Objective: Fibromyalgia (FM) is a concerning chronic disease showing as widespread pain, muscle stiffness, sleep disturbances, chronic fatigue, and depressed mood, for which no sound therapy is yet available to...
3.
Valdenassi L, Rossi E, Corsetti M, Sarli R, Bellardi D, Chirumbolo S, et al.
Eur Rev Med Pharmacol Sci
. 2022 Sep;
26(16):5911-5917.
PMID: 36066166
Objective: Sjögren syndrome (SS) is an autoimmune disorder, affecting about 16,000 individuals in Italy, yet lacking a standardized therapy protocol and a plain inclusion in the reimbursed healthcare services. This...
4.
Chirumbolo S, Simonetti V, Valdenassi L, Pandolfi S, Vaiano F, Franzini M
Eur Rev Med Pharmacol Sci
. 2022 Apr;
26(7):2224-2226.
PMID: 35442506
No abstract available.
5.
Tirelli U, Franzini M, Valdenassi L, Pisconti S, Taibi R, Torrisi C, et al.
Eur Rev Med Pharmacol Sci
. 2021 Oct;
25(18):5871-5875.
PMID: 34604980
Objective: Post-acute sequelae of SARS-CoV2 infection (PASC) are a novel terminology used to describe post-COVID persistent symptoms, mimicking somehow the previously described chronic fatigue syndrome (CFS). In this manuscript, we...
6.
Schwartz K, Beebe-Dimmer J, Hastert T, Ruterbusch J, Mantey J, Harper F, et al.
J Cancer Surviv
. 2020 Oct;
15(4):630-640.
PMID: 33067774
Purpose: Relatively little is known about caregivers of African American cancer survivors. Our goal was to identify the extent of burden among this group of caregivers. Methods: Responses from 560...
7.
Radtke G, Taverna D, Menguy N, Pandolfi S, Courac A, Le Godec Y, et al.
Phys Rev Lett
. 2020 Jan;
123(25):256001.
PMID: 31922788
Orientation-dependent aloof-beam vibrational electron-energy-loss spectroscopy is carried out on uniaxial icosahedral B_{12}P_{2} submicron crystals. We demonstrate that the high sensitivity of the signal to the crystal orientation allows for an...
8.
Alagna F, Caceres M, Pandolfi S, Collani S, Mousavi S, Mariotti R, et al.
Front Plant Sci
. 2019 Jul;
10:725.
PMID: 31293602
Olive, representing one of the most important fruit crops of the Mediterranean area, is characterized by a general low fruit yield, due to numerous constraints, including alternate bearing, low flower...
9.
Steklov M, Pandolfi S, Baietti M, Batiuk A, Carai P, Najm P, et al.
Science
. 2018 Nov;
362(6419):1177-1182.
PMID: 30442762
The leucine zipper-like transcriptional regulator 1 (LZTR1) protein, an adaptor for cullin 3 (CUL3) ubiquitin ligase complex, is implicated in human disease, yet its mechanism of action remains unknown. We...
10.
Pandolfi S, Montagnani V, Lapucci A, Stecca B
Cell Death Differ
. 2015 May;
22(12):2006-19.
PMID: 26024388
HEDGEHOG (HH) signaling is a key regulator of tissue development and its aberrant activation is involved in several cancer types, including melanoma. We and others have shown a reciprocal cross...